GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarti Drugs Ltd (BOM:524348) » Definitions » Total Assets

Aarti Drugs (BOM:524348) Total Assets : ₹24,324 Mil (As of Mar. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Aarti Drugs Total Assets?

Aarti Drugs's Total Assets for the quarter that ended in Mar. 2024 was ₹24,324 Mil.

During the past 12 months, Aarti Drugs's average Total Assets Growth Rate was -0.10% per year. During the past 3 years, the average Total Assets Growth Rate was 11.10% per year. During the past 5 years, the average Total Assets Growth Rate was 12.30% per year. During the past 10 years, the average Total Assets Growth Rate was 11.20% per year.

During the past 13 years, Aarti Drugs's highest 3-Year average Total Assets Growth Rate was 20.40%. The lowest was 4.40%. And the median was 12.00%.

Total Assets is connected with ROA %. Aarti Drugs's annualized ROA % for the quarter that ended in Mar. 2024 was 7.78%. Total Assets is also linked to Revenue through Asset Turnover. Aarti Drugs's Asset Turnover for the quarter that ended in Mar. 2024 was 0.25.


Aarti Drugs Total Assets Historical Data

The historical data trend for Aarti Drugs's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aarti Drugs Total Assets Chart

Aarti Drugs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15,765.01 17,660.14 22,079.58 24,213.98 24,323.60

Aarti Drugs Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24,213.98 - 23,518.30 - 24,323.60

Aarti Drugs Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Aarti Drugs's Total Assets for the fiscal year that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (A: Mar. 2024 )+Total Liabilities (A: Mar. 2024 )
=12819.658+11503.942
=24,324

Aarti Drugs's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=12819.658+11503.942
=24,324

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aarti Drugs  (BOM:524348) Total Assets Explanation

Total Assets is connected with ROA %.

Aarti Drugs's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=1892.4/( (0+24323.6)/ 1 )
=1892.4/24323.6
=7.78 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Aarti Drugs's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=6199.9/( (0+24323.6)/ 1 )
=6199.9/24323.6
=0.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Aarti Drugs Total Assets Related Terms

Thank you for viewing the detailed overview of Aarti Drugs's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Aarti Drugs (BOM:524348) Business Description

Traded in Other Exchanges
Address
Road No. 29, Plot Number 109-D, Mahendra Industrial Estate, Ground Floor, Sion (East), Mumbai, MH, IND, 400 022
Aarti Drugs Ltd is a pharmaceutical company. It offers active pharmaceutical ingredients (APIs) in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antibiotic, antidiabetic, and vitamins among others. The product offerings of the company comprise Aceclofenac, Celecoxib, Moxifloxacin, and others. The firm generates the majority of its revenue from India.

Aarti Drugs (BOM:524348) Headlines

No Headlines